PAUL HOPKINS to Apolipoprotein B-100
This is a "connection" page, showing publications PAUL HOPKINS has written about Apolipoprotein B-100.
Connection Strength
0.203
-
Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipoprotein B Loss-of-Function Mutations. Am J Cardiol. 2020 03 15; 125(6):880-886.
Score: 0.163
-
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia. J Clin Lipidol. 2017 Nov - Dec; 11(6):1338-1346.e7.
Score: 0.035
-
The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a). Clin Invest Med. 1991 Apr; 14(2):146-52.
Score: 0.006